The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
PROTA: A phase I clinical trial combining an oncolytic adenovirus encoding for TNFa and IL-2 with pembrolizumab for the treatment of platinum-resistant or -refractory ovarian cancer.
 
Joao Manuel Santos
Employment - Daiichi Sankyo (I); TILT Biotherapeutics; TILT Biotherapeutics (I)
Stock and Other Ownership Interests - TILT Biotherapeutics
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Matthew Stephen Block
Research Funding - Alkermes; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Immune Design (Inst); Marker, Inc. (Inst); Merck (Inst); nference; Pharmacyclics (Inst); Regeneron; Sorrento Therapeutics (Inst); TILT Biotherapeutics; Transgene (Inst); Viewpoint Molecular Targeting
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting
 
Johanna Unelma Maenpaa
Honoraria - Eisai
 
James Clubb
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Tuomo Alanko
Employment - Docrates Cancer Center
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; SERVIER
Research Funding - AbbVie (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst); TILT Biotherapeutics (Inst)
Expert Testimony - AstraZeneca; Eisai; Incyte; Nordic Drugs
Travel, Accommodations, Expenses - AstraZeneca; Merck; MSD; Pfizer
 
Grace Mei Yee Choong
No Relationships to Disclose
 
Carolyn Klampe
No Relationships to Disclose
 
Megan Grudem
No Relationships to Disclose
 
Santeri Pakola
No Relationships to Disclose
 
Lyna Haybout
No Relationships to Disclose
 
Dafne Carolina Alves Quixabeira
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Tatiana Kudling
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Elise Jirovec
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Julia Wanda Cohen
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Claudia Kistler
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
 
John Goldfinch
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
 
Suvi Sorsa
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Anna Kanerva
Employment - TILT Biotherapeutics (I)
Leadership - TILT Biotherapeutics (I)
Stock and Other Ownership Interests - Circio Holdings ASA (I); TILT Biotherapeutics (I)
Research Funding - TILT Biotherapeutics (I)
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics (I)
Travel, Accommodations, Expenses - TILT Biotherapeutics (I)
 
Victor Cervera
Employment - TILT Biotherapeutics
Stock and Other Ownership Interests - TILT Biotherapeutics
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
 
Akseli Hemminki
Employment - TILT Biotherapeutics
Leadership - TILT Biotherapeutics
Stock and Other Ownership Interests - Circio Holdings ASA; TILT Biotherapeutics
Research Funding - TILT Biotherapeutics
Patents, Royalties, Other Intellectual Property - TILT Biotherapeutics
Travel, Accommodations, Expenses - TILT Biotherapeutics